Back to top

OCUL’s OTX-TKI Extension Study: Long-Term Safety Data Could Shape Wet AMD Market

Ocular Therapeutix Inc ($OCUL) announced an update on their ongoing clinical study. Ocular Therapeutix Inc. is running a new follow-up study to tra...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Ocular Therapeutix, Inc. (OCUL)